HOME >> MEDICINE >> NEWS
C-reactive proteins: Should everyone be tested?

(Philadelphia, PA) -- In the last year, a number of studies have focused on the C-reactive protein (CRP) inflammatory risk factor for heart disease. Using high-sensitivity assays (hsCRP), we are able to measure CRP at lower levels than previously possible. These low levels of CRP (hsCRP) are related to chronic, low grade inflammation, which is associated with heart disease. Many of these studies reported on the relationship of hsCRP to first myocardial or anginal attack, recurrence of coronary heart disease incidents, and increased prognosis of heart disease when elevated hsCRP exists with other risk factors. Other published materials have focused on the laboratory methods used for identifying hsCRP, and have expressed concern about results that stem from using different test methods to identify hsCRP. A Cardiac Risk Survey released earlier this year by the College of American Pathologists (CAP) underscored the need for standardizing the results of five different classes used by labs to identify hsCRP. The Centers for Disease Control and Prevention (CDC) have issued recommendations to address these concerns.

Presentation at the 55th Annual AACC Meeting

How important is hsCRP as an indicator of cardiovascular disease? What is the role of laboratories and are readings affected by different laboratory methods and a lack of standardization? The Centers for Disease Control and Prevention (CDC) has examined these questions and developed recommendations for the public and leaders of the nation's clinical laboratories.

These recommendations will be discussed by Gerald R. Cooper, MD, PhD, of the Centers for Disease Control and Prevention, Atlanta, GA. Dr. Cooper will deliver his remarks entitled, "C-Reactive Protein: A New Inflammatory Risk Factor for Cardiovascular Disease," during the 55th Annual Meeting of the American Association of Clinical Chemistry (AACC) being held July 20-24, 2003 at the Pennsylvania Convention Center, Philadelphia
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Association for Clinical Chemistry
21-Jul-2003


Page: 1 2 3

Related medicine news :

1. Vitamin C reduces level of C-reactive protein, finds UC Berkeley-led study
2. C-reactive proteins do not predict early osteoarthritis
3. C-reactive protein more than a heart disease marker
4. High levels of C-reactive protein indicate early heart disease
5. Should medical students have earlier contact with patients?
6. Should nurses conduct breast cancer follow-up visits?
7. Should compulsory screening of immigrants be part of UK public health policy?
8. Should the standard guidelines for assessing prostate cancer control be changed?
9. Should living liver donation be available in the NHS?
10. Should ambulance crews perform emergency breathing procedure?
11. Should people with dementia be electronically tagged?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... Everybody has ... it while others prefer to read it, and some people don't like it at ... pornography. Here's what they found: , Erotic literature can give readers a taste of ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Aesthetic Channel has recently ... Talei has come up with a proprietary technique that he calls the AuraLyft ... have dropped. For all ages, patients can expect to look refreshed, rejuvenated, and revitalized. ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia ... Sept. 18 to 20. , The two-day conference is focused on advancing scientific ... of improving patients’ lives and eliminating racial breast cancer-related disparities. The conference theme ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... ... with Private Flood Insurance offerings. With the Federal Emergency Management Agency’s (FEMA) recent ... across the United States. In 2012, the Biggert-Waters Act was enacted to reflect ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/9/2017)... INDIANAPOLIS , June 9, 2017 More ... a further effort to help spread lessons learned from ... the International Diabetes Federation (IDF) and Eli Lilly and ... for the second phase of the Bringing Research in ... reaffirming their commitment to helping people with diabetes effectively ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
Breaking Medicine Technology:
Cached News: